Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
May 27, 2026, 3:44 PM EST
Syros Pharmaceuticals Employees
Syros Pharmaceuticals had 68 employees as of December 31, 2023. The number of employees decreased by 49 or -41.88% compared to the previous year.
Employees
68
Change (1Y)
-49
Growth (1Y)
-41.88%
Revenue / Employee
$5,676
Profits / Employee
-$1,438,456
Market Cap
5.37K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 68 | -49 | -41.88% |
| Dec 31, 2022 | 117 | -7 | -5.65% |
| Dec 31, 2021 | 124 | 21 | 20.39% |
| Dec 31, 2020 | 103 | 20 | 24.10% |
| Dec 31, 2019 | 83 | 7 | 9.21% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Syros Pharmaceuticals News
- 1 year ago - Syros Pharmaceuticals sells Tamibarotene assets to Rege Nephro - TheFly
- 1 year ago - Syros Pharmaceuticals trading resumes - TheFly
- 1 year ago - Syros Pharmaceuticals voluntarily delists from Nasdaq, deregisters common stock - TheFly
- 1 year ago - Syros Pharmaceuticals trading halted, news pending - TheFly
- 1 year ago - Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration - Business Wire
- 1 year ago - Syros Pharmaceuticals downgraded to Hold from Buy at TD Cowen - TheFly
- 1 year ago - Syros Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 1 year ago - Syros downgraded to Market Perform from Outperform at JMP Securities - TheFly